Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC)

Chinese Journal of Cancer Research

Volumn 27, Issue 3, 2015, Pages 301-308

  Yang, Xue Ning ^a   Huang, Ling ^a   Chen, Yu ^a   An, She Juan ^a   Zhang, Xu Chao ^a   Liao, Ri Qiang ^a   Su, Jian ^a   Wu, Yi Long ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Epidermal growth factor receptor (EGFR); MAGE A3; Non small cell lung cancer (NSCLC); Single nucleotide polymorphism (SNP)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MELANOMA ANTIGEN 3; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHINESE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; NON SMALL CELL LUNG CANCER; POINT MUTATION; POLYMORPHIC LOCUS; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 84940187549     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2014.11.03     Document Type: Article

References (15)

1. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
2. Kocher T, Schultz-Thater E, Gudat F, et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res 1995;55:2236-9.
3. Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol 1997;9:684-93.
4. Gure AO, Chua R, Williamson B, et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005;11:8055-62.
5. Weynants P, Lethé B, Brasseur F, et al. Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer 1994;56:826-9.
6. Brichard VG, Lejeune D. GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. Vaccine 2007;25 Suppl 2:B61-71.
7. Yanagawa N, Tamura G, Oizumi H, et al. MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer. Anticancer Res 2011;31:171-5.
8. Ponder BA. Cancer genetics. Nature 2001;411:336-41.
9. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med 2003;54:73-87.
10. Herbst RS, Onn A, Sandler A. Angiogenesis and lung cancer: prognostic and therapeutic implications. J Clin Oncol 2005;23:3243-56.
11. Boël P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-75.
12. Ito S, Kawano Y, Katakura H, et al. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer. Lung Cancer 2006;51:79-88.
13. Peng JR, Chen HS, Mou DC, et al. Expression of cancer/ testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Cancer Lett 2005;219:223-32.
14. Nagorsen D, Scheibenbogen C, Marincola FM, et al. Natural T cell immunity against cancer. Clin Cancer Res 2003;9:4296-303.
15. De Smet C, De Backer O, Faraoni I, et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 1996;93:7149-53.